An agonist of receptors, adrenergic alpha-2 that is used in veterinary medicine for its analgesic and sedative properties. It is the racemate of dexmedetomidine.
Administered intravenously, dexmedetomidine is indicated for the sedation of initially intubated and mechanically ventilated patients during treatment in intensive care settings, and for the sedation of non-intubated patients prior to and/or during surgery and other procedures. It is also available as a buccally- or sublingually-administered dissolvable film for the acute treatment of agitation associated with schizophrenia or bipolar I or II disorder.
Ain Shams University Hospital, Cairo, EL Abassia, Egypt
Seoul National University Hospital, Seoul, Korea, Republic of
Dr. Haris Chohan, Karachi, Sindh, Pakistan
Ain Shams University, Cairo, Abassia, Egypt
PLA General Hospital, Beijing, China
Beijing TianTan Hospital,Capital Medical University, Beijing, Beijing,China, China
China International Neuroscience, Beijing, Beijing, China
Sadik A Sadik, Shibīn Al Kawm, Menoufiya, Egypt
Ashraf magdy Eskandr, Shibīn Al Kawm, Menoufiya, Egypt
Osama A Elmorsy, Shibīn Al Kawm, Menoufiya, Egypt
Inselspital Bern, Bern, Switzerland
Massachusetts General Hospital, Boston, Massachusetts, United States
Tanta University Hospitals, Tanta, ElGharbiaa, Egypt
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.